These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14064765)

  • 21. Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.
    Purrucker JC; Haas K; Rizos T; Khan S; Poli S; Kraft P; Kleinschnitz C; Dziewas R; Binder A; Palm F; Jander S; Soda H; Heuschmann PU; Veltkamp R;
    Stroke; 2017 Jan; 48(1):152-158. PubMed ID: 27899756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANTICOAGULANT TREATMENT OF TRANSIENT ISCHEMIC ATTACKS AND PROGRESSING STROKES.
    WHISNANT JP
    Mod Treat; 1965 Jan; 2():25-35. PubMed ID: 14257805
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary data on application of anticoagulants and coagulants in treatment and prevention of disorders of cerebral circulation].
    SMIRNOV VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(8):1001-4. PubMed ID: 13531918
    [No Abstract]   [Full Text] [Related]  

  • 24. An Audit of Thrombophilia Testing in Patients with Ischemic Stroke or Transient Ischemic Attack: The Futility of Testing.
    Gavva C; Johnson M; De Simone N; Sarode R
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3301-3305. PubMed ID: 30143267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DISEASES INCIDENTAL TO TONSILLECTOMY, WITH SPECIAL REFERENCE TO SYMPTOMS OF SHOCK].
    NOSAKA Y; SADANAGA M; UENO Y
    Jibiinkoka; 1963 Dec; 35():1107-10. PubMed ID: 14101129
    [No Abstract]   [Full Text] [Related]  

  • 26. THE TREATMENT OF RECURRING CEREBRAL ISCHEMIC PHENOMENA.
    SCHEINBERG P; RICE-SIMONS RA
    Geriatrics; 1964 Dec; 19():887-93. PubMed ID: 14226250
    [No Abstract]   [Full Text] [Related]  

  • 27. [Substances modifying blood coagulation; coagulants and anticoagulants].
    CAVIER R
    Prod Pharm; 1954 Jun; 9(6):335-41; contd. PubMed ID: 13194744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dynamics of fibrinolysis and several components of blood coagulation in various disorders of cerebral circulation].
    Karpinskaia VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(1):41-50. PubMed ID: 5647161
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of the separation of fibrinogen and antihemophilic factor (AHF) in canine, porcine, and human plasmas.
    WAGNER RH; RICHARDSON BA; BRINKHOUS KM
    Thromb Diath Haemorrh; 1958 Apr; 1(1):1-8. PubMed ID: 13569420
    [No Abstract]   [Full Text] [Related]  

  • 30. Coagulant and anticoagulant agents in snke venoms.
    de KLOBUSITZKY
    Am J Med Sci; 1961 Jul; 242():107-23. PubMed ID: 13756917
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dicoumarin in course of certain forms of hypertension; coagulant and anticoagulant therapy].
    DUMAS A
    Concours Med; 1951 Sep; 73(37):3057-9. PubMed ID: 14870421
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the indicators of blood coagulation in acute cerebral ischemia].
    Burtsev EM; Shprakh VV; Mikhalevich IM
    Sov Med; 1983; (8):22-7. PubMed ID: 6648649
    [No Abstract]   [Full Text] [Related]  

  • 33. THE TREATMENT OF CEREBROVASCULAR DISEASE.
    CARTER AB
    Practitioner; 1964 Jan; 192():49-61. PubMed ID: 14102402
    [No Abstract]   [Full Text] [Related]  

  • 34. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 35. CEREBRAL ANGINA.
    CURRY HB
    J S C Med Assoc; 1964 Dec; 60():373-7. PubMed ID: 14232423
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment of coagulopathic syndromes in ischemic stroke].
    Shirokov EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(7):23-4. PubMed ID: 1661474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of coagulant principles in snake venoms by dextran sulfate, a synthetic anticoagulant of bacterial origin].
    GRASSET E; SCHWARTZ DE
    Schweiz Z Pathol Bakteriol; 1954; 17(4):514-20. PubMed ID: 13225707
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibilities of mathematical evaluation of blood coagulation capacity in patients with ischemic heart disease being treated with anticoagulants].
    Khalfen ESh; Zaferman DM
    Kardiologiia; 1970 Aug; 10(8):107-11. PubMed ID: 5479893
    [No Abstract]   [Full Text] [Related]  

  • 40. A STUDY OF THE COAGULANT ACTION OF EIGHT SNAKE VENOMS.
    NAHAS L; MACFARLANE RG; DENSON KW
    Thromb Diath Haemorrh; 1964 Dec; 12():355-67. PubMed ID: 14254694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.